clomiphene

  1. Nelson Vergel

    Repros says FDA seeks more studies for clomiphene drug

    Repros is developing Androxal® , a single isomer of clomiphene citrate and is an orally active proprietary small molecule compound. Repros Therapeutics Inc said the U.S. health regulator sought additional studies of its testosterone replacement drug, Androxal, and recommended that a safety...

Beyond Testosterone Podcast

Back
Top